Abstract:Lichen planus follicularis tumidus (LPFT) is an extremely rare variant of lichen planus characterized by white to yellow milia-like cysts and comedones on a violaceous to hyperpigmented plaque most commonly involving retroauricular area. Clinically, it resembles milia
en plaque
. It is usually asymptomatic, more common in middle-aged females. Histopathologically, it has features of lichen planopilaris along with follicular cysts in dermis surrounded by lichenoid infiltrate. We are report… Show more
“…LPFT may be associated with other forms of LP 4 . However, our patient had no cutaneous or mucosal lesions of classic LP.…”
Section: Discussionmentioning
confidence: 57%
“…Lesions are usually asymptomatic but may be mildly pruritic. 4 The most commonly affected site is the postauricular area, either unilaterally or bilaterally. 2 However, ears, eyelids, cheeks, chin, nose, and scalp may also be involved.…”
Section: Discussionmentioning
confidence: 99%
“…LPFT is an uncommon type within the diverse spectrum LP that most commonly affects middle‐aged females and clinically manifests as erythematous to violaceous plaques that have a soft consistency. Lesions are usually asymptomatic but may be mildly pruritic 4 …”
Section: Discussionmentioning
confidence: 99%
“…2,3 LPFT is recognized histopathologically by the presence of cystically dilated follicular infundibula in the dermis, encircled by infiltrates of lymphocytes and histiocytes. 4 Here, we describe a case of LPFT affecting the ala of the nose in a patient with a history of hepatitis C. To our knowledge, fewer than 25 cases have been reported in the medical literature. 5…”
mentioning
confidence: 90%
“…LPFT is recognized histopathologically by the presence of cystically dilated follicular infundibula in the dermis, encircled by infiltrates of lymphocytes and histiocytes 4 …”
Lichen planus follicularis tumidus in a patient with a history of hepatitis C 1 | INTRODUCTION Lichen planus follicularis tumidus (LPFT) is a very rare type of lichen planus (LP) that was first described by Belaïch et al. in 1977 when they reported three cases of retroauricular LPFT. 1
“…LPFT may be associated with other forms of LP 4 . However, our patient had no cutaneous or mucosal lesions of classic LP.…”
Section: Discussionmentioning
confidence: 57%
“…Lesions are usually asymptomatic but may be mildly pruritic. 4 The most commonly affected site is the postauricular area, either unilaterally or bilaterally. 2 However, ears, eyelids, cheeks, chin, nose, and scalp may also be involved.…”
Section: Discussionmentioning
confidence: 99%
“…LPFT is an uncommon type within the diverse spectrum LP that most commonly affects middle‐aged females and clinically manifests as erythematous to violaceous plaques that have a soft consistency. Lesions are usually asymptomatic but may be mildly pruritic 4 …”
Section: Discussionmentioning
confidence: 99%
“…2,3 LPFT is recognized histopathologically by the presence of cystically dilated follicular infundibula in the dermis, encircled by infiltrates of lymphocytes and histiocytes. 4 Here, we describe a case of LPFT affecting the ala of the nose in a patient with a history of hepatitis C. To our knowledge, fewer than 25 cases have been reported in the medical literature. 5…”
mentioning
confidence: 90%
“…LPFT is recognized histopathologically by the presence of cystically dilated follicular infundibula in the dermis, encircled by infiltrates of lymphocytes and histiocytes 4 …”
Lichen planus follicularis tumidus in a patient with a history of hepatitis C 1 | INTRODUCTION Lichen planus follicularis tumidus (LPFT) is a very rare type of lichen planus (LP) that was first described by Belaïch et al. in 1977 when they reported three cases of retroauricular LPFT. 1
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.